Events

14 March 2012

BACR Gray Institute meeting 2012

Location: St Catherine's College, University of Oxford, UK

This meeting will address DNA damage repair in order to identify the potential of DNA repair proteins as targets and biomarkers for cancer therapy.

Perspectives in Clinical Proteomics Conference 2012                       14-15 March 2012         

Location: Wellcome Trust Conference Centre, Hinxton, Cambridge

Perspectives in Clinical Proteomics is a proteomics training workshop and a 2-day conference jointly sponsored by the Wellcome Trust and the European Bioinformatics Institute (EBI).

This conference will focus on the attributes of successful biomarker translation, aspects of emerging quantitative biomarker assays in the clinical chemistry laboratory, as well as in vitro diagnostic development and regulatory considerations.

EORTC 50th Anniversary Conference                                                          15 - 16 March 2012

Location: Square Brussels Meeting Centre, Brussels

This conference, organised by the European Organisation for Research and Treatment of Cancer (EORTC) takes place on its 50th anniversary. The EORTC Network comprises over 300 hospitals and cancer centres in over 30 countries which include some 2,500 collaborators from all disciplines involved in cancer treatment and research. The EORTC offers an integrated approach to drug development, drug evaluation programs and practice changing academic clinical trials that establish State of the Art treatment.

The conference offers a unique opportunity to gather all the partners (including national research organizations, health authorities, patient advocacy groups, European Commission, cancer leagues, and the pharmaceutical industry) involved in the EORTC mission.

15-18 April 2012

28th IABCR/Breakthrough Breast Cancer Conference

Location: Palace Hotel, Manchester, UK

The purpose of the meeting is to bring together basic and translational scientists with the clinicians who will drive forward the evaluation of these drugs in patients treated with radiotherapy.

11-13 June 2012

Rab GTPases and their interacting proteins in health and disease

Biochemical Society Breakthrough Science 

Location: University College Cork, Republic of Ireland

Rab GTPases localise to distinct cellular organelles and regulate all stages of intracellular membrane trafficking in eukaryotic cells. Their activity state and functional effects are controlled and or mediated by several interacting proteins, including guanine nucleotide exchange proteins, GTPase Activating proteins, effector and motor proteins. Rab GTPase function is essential for a vast range of normal cellular physiological processes, ranging from Long Term Potentiation (LTP) to cellular uptake of glucose in response to insulin signalling.

In recent years, Rabs, or their interactors, have been implicated in a wide range of genetic diseases. Some examples include choroideremia, Niemann-Pick disease, Griscelli syndrome, cancer aggressiveness, Charcot-Marie-Tooth disease, X-linked mental retardation, Huntington's disease, Alzheimer's disease, Batten's disease, osteopetrosis, Crohn's disease, diabetic nephropathy, cardiomyopathy, Carpenter's syndrome, Sjogren's syndrome and platelet disorders.

14-15 June 2012

Cancer Outcomes conference

Location: Birmingham

The NCIN and cancer registries have seen unprecedented growth in the demand for their services, as data-processor, producers of information and intelligence, and as providers of high quality data to drive innovative new research to improve outcomes. The conference showcases the new and applied knowledge, as well as allowing service users and consumers direct access to participants ranging from researchers to policy makers.

1-4 July 2012

Membrane Dynamics in Cancer

Location: Beatson Institute, Glasgow

It is now clear that intracellular membrane trafficking contributes to processes which are linked to cancer. The aim of the conference is to discuss the role of membrane transport in cellular processes such as autophagy, cell migration, receptor signalling, lysosome exocytosis and exosome release in the context of their effects on tumour growth, survival and metastasis. We have assembled a programme of speakers who are leaders in particular aspects of these timely topics, with the intention of exploring new avenues for future collaborative research involving centres throughout the world.

7-10 July 2012

22nd Biennial Congress of the European Association for Cancer Research

Location: Barcelona, Spain

Join all stakeholders in the field of basic and translational cancer research at the 22nd Biennial Congress of the European Association for Cancer Research. This premier educational and scientific event will highlight the very latest data that is set to advance the development of cancer treatment and practice.

Research Bursaries for students and graduates are available for this scheme. Further details can be found here. 

12 September 2012

BACR Chasing Cancer like stem cells

Location: Harrogate, UK

Do cancer stem-cells really exist?  What is the evidence for and against? How can we study and exploit these evasive cells for therapeutic benefit? Have your say and place your vote.

29 November 2012

Development of Cancer medicines- 

in association with Royal Society of Medicine Section of Oncology

Location: London

What are the latest advances in preclinical in vivo modelling?  How can models be used to reveal cancer targets, develop clinically translatable biomarkers or assess therapeutic response meaningfully?